Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 38

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 1
Chunk 38
---
 7,692 23,475 (2,963)INTEREST EXPENSE, NET(20,549)(23,841)(42,580)(47,613)OTHER INCOME (EXPENSE), NET1,818 (3,384)55 (5,725)GAIN ON SALE OF BUSINESS41,823 — 41,823 — INCOME (LOSS) BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF UNCONSOLIDATED AFFILIATES33,679 (19,533)22,773 (56,301)PROVISION FOR INCOME TAXES(1,178)(1,873)(5,748)(4,576)NET INCOME (LOSS) FROM CONSOLIDATED COMPANIES32,501 (21,406)17,025 (60,877)EQUITY IN EARNINGS OF UNCONSOLIDATED AFFILIATES2,837 — 2,837 — NET INCOME (LOSS)$35,338 $(21,406)$19,862 $(60,877)NET INCOME (LOSS) PER SHARE  Basic$1.43 $(0.88)$0.81 $(2.51)Diluted$1.43 $(0.88)$0.80 $(2.51)WEIGHTED AVERAGE NUMBER OF SHARES  Basic24,645 24,393 24,593 24,295 Diluted24,708 24,393 24,746 24,295 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Table of Contents

ICU MEDICAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)

(In thousands)

 Three months ended June 30,Six months ended June 30, 2025202420252024NET INCOME (LOSS)$35,338 $(21,406)$19,862 $(60,877)Other comprehensive income (loss), net of tax:Cash flow hedge adjustments, net of tax of $(415) and $(2,054) for the three months ended June 30, 2025 and 2024, respectively, and $(2,247)and $(25) for the six months ended June 30, 2025 and 2024, respectively.(8